Skip to content
Home/Companies/Biotech/Chain Biotechnology

Chain Biotechnology

Biotech·UK·Exited 2026·Held 9yr
Entry
2017
Hold
9yr
Exit
2026

Who owns Chain Biotechnology?

Chain Biotechnology was owned by Future Planet Capital through UK Innovation and Science Seed Fund (2012 vintage) from 2017 to 2026.

Hand-verified · updated 2026-08-09

Future Planet Capital
Investor
Future Planet Capital
UK Innovation and Science Seed Fund · 2012 · VC

Key facts

HQUK
SectorBiotech
StatusAcquired
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2026

More from UK Innovation and Science Seed Fund

Other portfolio companies in the same fund.

52North Health
52North Health
Active
HealthTechUK
Akrivia Health
Akrivia Health
Active
HealthTechUK
Antiverse
Antiverse
Active
BiotechUK
CellCentric
CellCentric
Active
BiotechUK
Clare Sys
Clare Sys
Active
Deep TechUK
Crescendo Biologics
Crescendo Biologics
Active
BiotechUK

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Inits Group
Inits Group
Active
Sofilaro GestionFrance
Isavy Biotech
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Track Chain Biotechnology

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Chain Biotechnology.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue